Skip to main content
NIH funding notice RFA-HL-24-015

Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)

Closed on October 27, 2023.

Posted
September 6, 2023
Close date
October 27, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 renewal
First-year cost
$462,000
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF ROCHESTER1

Most frequent study sections

  1. Special Emphasis Panel (ZHL1 CSR-I (M1))1
1 award under RFA-HL-24-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2024BioRepository for INvestigation of Diseases of the Lung (BRINDL) - Phase III2U01HL148861-06Pryhuber, Gloria SUNIVERSITY OF ROCHESTER, NYFirst-year cost $462,000Study section ZHL1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-HL-24-015: Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed) | ScienceDex | ConductScience